Questions & explanations
1. What design features in a plasmid can increase protein expression in a cell-free system?
To get high protein expression, the plasmid should have a strong promoter, like the T7 promoter, which is a DNA sequence that tells the machinery to start making RNA. It also needs a good ribosome binding site (RBS), a short RNA sequence where the ribosome attaches to start making protein. The gene should be placed after these signals. Also, using a terminator (a stop signal) helps the machinery finish properly. Sometimes adding a tag (like His-tag) can help purify the protein but may affect yield. The plasmid backbone should be stable and not have sequences that slow down the machinery. Finally, the DNA sequence of the gene itself can be optimized for the cell-free system's preferred codons (the three-letter words for amino acids).
2. What does 'energy efficiency' mean for a network-based biocomputer?
Energy efficiency in a network-based biocomputer means how little energy it uses to do a calculation. These computers use molecules like DNA to process information, and they need very little energy compared to electronic computers. For example, a DNA computer might solve a problem using chemical reactions that happen at room temperature, while an electronic computer would need electricity and cooling. The energy is used mainly to move molecules and start reactions, not to power transistors. This makes biocomputers potentially much more efficient for certain tasks, especially large parallel computations. However, they are slower and harder to program than electronic computers.
3. What is a major limitation of cellular computing compared to electronic computing?
Cellular computing is much slower: a single operation in a cell can take minutes to hours, while electronic computers do billions of operations per second. Cells also have limited reliability: their behavior can vary due to random noise in gene expression, and they can mutate over time. Additionally, it is hard to design complex circuits because the cell's environment is messy and interactions are hard to predict. Finally, cells need nutrients and a controlled environment to survive, whereas electronic chips work in many conditions. So cellular computing is not a replacement for silicon, but it may be useful for tasks that need self-repair or interaction with biology.
4. Why is a plasmid often used as the DNA template in cell-free protein synthesis?
A plasmid is a small, circular DNA molecule that can carry a gene for a protein we want to make. In cell-free systems, using a plasmid is convenient because it is stable, easy to add in known amounts, and can be designed to have strong signals for starting protein production. Plasmids can also be copied many times inside cells, but in cell-free systems, we add them directly. The circular shape and supercoiling (tight twisting) of the plasmid can affect how well the protein-making machinery reads the gene. To get high expression, we design the plasmid with a strong promoter (a start signal) and a good ribosome binding site (a place for the protein factory to attach).
5. How can cell-free systems be used to produce industrial enzymes?
Cell-free systems use extracts from broken cells that contain the machinery to make proteins. To produce an industrial enzyme, we add a DNA template (like a plasmid) that carries the gene for that enzyme. The system then makes the enzyme directly in a test tube. This is useful because we can produce enzymes that are hard to make in living cells, for example, if they are toxic to cells. We can also control the reaction conditions, like temperature and pH, to optimize yield. The enzyme can be harvested without needing to break open cells. This method is faster than traditional fermentation and can be used to make small amounts of many different enzymes for testing.
6. How is the activity of an enzyme produced in a cell-free system measured?
Enzyme activity is measured by how fast it converts a substrate (the molecule it acts on) into a product. For example, if the enzyme breaks down a sugar, we can measure the amount of product formed over time using a color change or a light signal. A common method is to use a substrate that changes color when the enzyme works, and we measure the color intensity with a spectrophotometer. The activity is often reported as units per milligram of protein, where one unit is the amount that converts one micromole of substrate per minute. We also check that the enzyme is properly folded and not aggregated. Comparing activity to a known standard helps confirm quality.
7. How does DNA computing solve NP-complete problems like the traveling salesman problem?
DNA computing solves NP-complete problems by using many DNA molecules to try all possible solutions at the same time. For the traveling salesman problem, which asks for the shortest route visiting many cities, Adleman's method creates DNA strands that represent different paths. Each strand encodes a sequence of cities. Then, chemical reactions select only the strands that visit each city exactly once and return to the start. Finally, the shortest strand is found by measuring its length. This parallel search uses the massive number of DNA molecules to check many possibilities in one experiment, but it still takes time and may not work for very large problems.
8. What is a key challenge for the future of cell-free synthetic biology?
A key challenge is improving the yield and cost-effectiveness of cell-free reactions. Currently, producing large amounts of protein is expensive compared to traditional fermentation. Researchers need to develop cheaper energy sources and more efficient extracts. Another challenge is scaling up from microliter to liter volumes without losing efficiency. Also, cell-free systems often have limited reaction times because energy runs out. Extending reaction duration is important for making more product. Addressing these challenges will require advances in biochemistry and engineering. If solved, cell-free systems could become a mainstream manufacturing platform.
9. How might cell-free systems enable new business models in biomanufacturing?
Cell-free systems allow decentralized production, meaning products can be made close to where they are needed. This could lead to small, local factories instead of huge centralized plants. For example, a hospital could make personalized medicines on-site using a cell-free device. This reduces shipping costs and allows rapid response to demand. Also, cell-free systems can be used for on-demand production of vaccines during outbreaks. Companies could sell compact machines and kits rather than bulk products. This shift could create new markets and reduce supply chain risks. However, regulatory frameworks must adapt to these distributed manufacturing models.
10. What is an emerging trend in cell-free synthetic biology that could expand its use?
One emerging trend is the development of freeze-dried cell-free systems that can be stored at room temperature. This makes them easy to ship and use in remote areas. For example, paper-based sensors with freeze-dried extracts can detect diseases without refrigeration. Another trend is using cell-free systems to make complex molecules like natural products or even materials. Researchers are also combining cell-free systems with microfluidics to create tiny labs-on-a-chip. These advances could lead to portable devices for diagnostics, biomanufacturing, and education. They make cell-free technology more accessible and practical for real-world applications.
11. Give an example of a commercial product that could be made using cell-free systems.
One example is making antibodies for diagnostic tests or therapeutics. Cell-free systems can produce antibody fragments quickly without using animal cells. This can lower production costs and speed up development. Another example is making enzymes for industrial use, like those in laundry detergents or food processing. Cell-free systems allow rapid prototyping of enzyme variants. Also, cell-free systems can produce personalized cancer vaccines by making proteins based on a patient's tumor DNA. These applications show the potential for cell-free systems in commercial biotechnology, though regulatory approval and manufacturing scale remain hurdles.
12. What is a major challenge for using cell-free systems in developing countries related to supplies?
A major challenge is getting the raw materials, like cell extracts and special chemicals, which often must be imported. These supplies can be expensive and may require cold shipping. Without a reliable supply chain, projects can stop. Also, local production of extracts from local bacteria might be possible but needs expertise. Another issue is the need for pure water and stable electricity for equipment like centrifuges. These infrastructure gaps can make it hard to run cell-free reactions consistently. Overcoming these challenges requires building local capacity and possibly creating open-source protocols that use locally available materials.